HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
26 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
XPC
XPC complex subunit, DNA damage recognition and repair factor
Chromosome 3 Β· 3p25.1
NCBI Gene: 7508Ensembl: ENSG00000154767.16HGNC: HGNC:12816UniProt: A0ABB0MVJ4
449PubMed Papers
21Diseases
0Drugs
220Pathogenic Variants
FUNCTIONAL ROLE
DNA RepairHub GeneTranscription Factor
RESEARCH IMPACT
Highly StudiedVariant-Rich
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
positive regulation of DNA-templated transcriptionUV-damage excision repairnucleoplasmprotein-containing complex bindingXeroderma pigmentosum complementation group Cxeroderma pigmentosum group Cxeroderma pigmentosumAbnormality of the skeletal system
✦AI Summary

XPC (Xeroderma Pigmentosum Complementation Group C) is a crucial DNA damage recognition protein that initiates global genome nucleotide excision repair (GG-NER) by detecting bulky DNA adducts, particularly UV-induced lesions 1. The protein functions as part of the XPC complex to sense DNA damage and transfer damaged DNA to the TFIIH core complex for verification and subsequent repair by XPF and XPG nucleases 1. Structurally, XPA positions the DNA lesion outside the TFIIH core complex, with XPB and XPD helicases working in opposition to facilitate lesion verification 1. Beyond DNA repair, XPC has multifaceted cellular roles including involvement in DNA damage response, cell fate decisions, and interactions with p53, p21, ARF, and p16 that can drive cells toward apoptosis, senescence, or tumorigenesis 2. Loss-of-function mutations in XPC cause xeroderma pigmentosum group C (XP-C), characterized by extreme photosensitivity and dramatically increased skin cancer risk due to accumulation of unrepaired UV damage 3. XPC-deficient cells exhibit impaired DNA repair capacity, reduced proliferative capacity, and abnormal inflammatory responses 3. Polymorphisms in XPC, particularly Lys939Gln, are associated with increased cancer susceptibility across multiple cancer types 4.

Sources cited
1
XPC recognizes DNA lesions and transfers damaged DNA to TFIIH complex, with XPA positioning lesions and XPB/XPD helicases facilitating verification
PMID: 37076618
2
XPC has roles beyond DNA repair including cell fate decisions through interactions with p53, p21, ARF, and p16
PMID: 35690409
3
XPC mutations cause xeroderma pigmentosum with photosensitivity, increased skin cancer risk, and cellular dysfunction
PMID: 39730601
4
XPC polymorphisms, particularly Lys939Gln, are associated with increased cancer susceptibility
PMID: 23400628
⚠Limited data available β€” This gene has 4 indexed publications. Summary and analysis may be incomplete.
Disease Associationsβ“˜21
Xeroderma pigmentosum complementation group COpen Targets
0.81Strong
xeroderma pigmentosum group COpen Targets
0.78Strong
xeroderma pigmentosumOpen Targets
0.72Strong
Abnormality of the skeletal systemOpen Targets
0.46Moderate
lung carcinomaOpen Targets
0.39Weak
Angiomatous MeningiomaOpen Targets
0.37Weak
Atypical MeningiomaOpen Targets
0.37Weak
gastrointestinal stromal tumorOpen Targets
0.37Weak
hemangioblastomaOpen Targets
0.37Weak
Meningothelial MeningiomaOpen Targets
0.37Weak
prostate carcinomaOpen Targets
0.37Weak
Transitional MeningiomaOpen Targets
0.37Weak
ovarian cancerOpen Targets
0.37Weak
hereditary neoplastic syndromeOpen Targets
0.34Weak
Familial prostate cancerOpen Targets
0.34Weak
Inherited cancer-predisposing syndromeOpen Targets
0.34Weak
non-small cell lung carcinomaOpen Targets
0.31Weak
lung adenocarcinomaOpen Targets
0.30Weak
urinary bladder carcinomaOpen Targets
0.30Weak
melanomaOpen Targets
0.30Weak
Xeroderma pigmentosum complementation group CUniProt
Pathogenic Variants220
NM_004628.5(XPC):c.1735C>T (p.Arg579Ter)Pathogenic
Xeroderma pigmentosum, group C|not provided|Xeroderma pigmentosum
β˜…β˜…β˜†β˜†2026β†’ Residue 579
NM_004628.5(XPC):c.2010T>A (p.Cys670Ter)Pathogenic
not provided|Xeroderma pigmentosum, group C
β˜…β˜…β˜†β˜†2026β†’ Residue 670
NM_004628.5(XPC):c.566_567del (p.Tyr189fs)Pathogenic
Xeroderma pigmentosum, group C|Xeroderma pigmentosum|not provided
β˜…β˜…β˜†β˜†2026β†’ Residue 189
NM_004628.5(XPC):c.1643_1644del (p.Val548fs)Pathogenic
Xeroderma pigmentosum, group C|Xeroderma pigmentosum|not provided|XPC-related disorder|See cases
β˜…β˜…β˜†β˜†2026β†’ Residue 548
NM_004628.5(XPC):c.2251-1G>CPathogenic
Xeroderma pigmentosum, group C|Xeroderma pigmentosum|not provided|XPC-related disorder
β˜…β˜…β˜†β˜†2026
NM_004628.5(XPC):c.342_343del (p.Ala116fs)Pathogenic
Xeroderma pigmentosum, group C|not provided
β˜…β˜…β˜†β˜†2026β†’ Residue 116
NM_004628.5(XPC):c.1677C>A (p.Tyr559Ter)Pathogenic
Xeroderma pigmentosum, group C|not provided
β˜…β˜…β˜†β˜†2025β†’ Residue 559
NM_004628.5(XPC):c.779+1G>TPathogenic
Xeroderma pigmentosum, group C|not provided
β˜…β˜…β˜†β˜†2025
NM_004628.5(XPC):c.420_423del (p.Glu141fs)Pathogenic
Xeroderma pigmentosum, group C|not provided|Xeroderma pigmentosum
β˜…β˜…β˜†β˜†2025β†’ Residue 141
NM_004628.5(XPC):c.1898del (p.Pro633fs)Pathogenic
not provided|Xeroderma pigmentosum, group C
β˜…β˜…β˜†β˜†2025β†’ Residue 633
NM_004628.5(XPC):c.2T>G (p.Met1Arg)Pathogenic
not provided|Xeroderma pigmentosum
β˜…β˜…β˜†β˜†2025β†’ Residue 1
NM_004628.5(XPC):c.463C>T (p.Arg155Ter)Pathogenic
Xeroderma pigmentosum|not provided|Xeroderma pigmentosum, group C
β˜…β˜…β˜†β˜†2025β†’ Residue 155
NM_004628.5(XPC):c.1103_1104del (p.Gln368fs)Pathogenic
Xeroderma pigmentosum, group C|Xeroderma pigmentosum|not provided|Familial prostate cancer
β˜…β˜…β˜†β˜†2025β†’ Residue 368
NM_004628.5(XPC):c.2226del (p.Gln742fs)Pathogenic
not provided|Xeroderma pigmentosum, group C
β˜…β˜…β˜†β˜†2025β†’ Residue 742
NM_004628.5(XPC):c.690dup (p.Ala231fs)Pathogenic
not provided|Xeroderma pigmentosum, group C
β˜…β˜…β˜†β˜†2025β†’ Residue 231
NM_004628.5(XPC):c.2289del (p.Ser765fs)Pathogenic
not provided|Xeroderma pigmentosum, group C
β˜…β˜…β˜†β˜†2025β†’ Residue 765
NM_004628.5(XPC):c.940del (p.Arg314fs)Pathogenic
Xeroderma pigmentosum, group C|Xeroderma pigmentosum
β˜…β˜…β˜†β˜†2025β†’ Residue 314
NM_004628.5(XPC):c.2263G>T (p.Glu755Ter)Pathogenic
not provided|Xeroderma pigmentosum, group C
β˜…β˜…β˜†β˜†2025β†’ Residue 755
NM_004628.5(XPC):c.2033+1G>ALikely pathogenic
Xeroderma pigmentosum, group C|not provided|Xeroderma pigmentosum|Sarcoma
β˜…β˜…β˜†β˜†2025
NM_004628.5(XPC):c.1872+1G>CPathogenic
Xeroderma pigmentosum, group C|not provided
β˜…β˜…β˜†β˜†2024
View on ClinVar β†—
Related Genes
CCNHProtein interaction100%ERCC2Protein interaction100%ATMProtein interaction99%CETN2Protein interaction99%ERCC8Protein interaction99%ERCC1Protein interaction99%
Tissue Expression6 tissues
Ovary
100%
Lung
71%
Liver
62%
Brain
43%
Heart
38%
Bone Marrow
27%
Gene Interaction Network
Click a node to explore
XPCCCNHERCC2ATMCETN2ERCC8ERCC1
PROTEIN STRUCTURE
Preparing viewer…
PDB2OBH Β· 1.80 Γ… Β· X-ray
View on RCSB β†—
Constraintβ“˜
LOEUFβ“˜
1.02LoF Tolerant
pLIβ“˜
0.00Tolerant
Observed/Expected LoF0.84 [0.69–1.02]
RankingsWhere XPC stands among ~20K protein-coding genes
  • #618of 20,598
    Most Researched449 Β· top 5%
  • #299of 5,498
    Most Pathogenic Variants220 Β· top 10%
  • #10,065of 17,882
    Most Constrained (LOEUF)1.02
Genes detectedXPC
Sources retrieved26 papers
Response timeβ€”
πŸ“„ Sources
26β–Ό
1
Generation and characterization of CRISPR-Cas9-mediated XPC gene knockout in human skin cells.
PMID: 39730601
Sci Rep Β· 2024
1.00
2
Lesion recognition by XPC, TFIIH and XPA in DNA excision repair.
PMID: 37076618
Nature Β· 2023
0.90
3
XPC-RAD23B enhances UV-DDB binding to DNA to facilitate lesion search in nucleotide excision repair.
PMID: 40530698
Nucleic Acids Res Β· 2025
0.80
4
Polymorphisms in XPC gene and risk for prostate cancer.
PMID: 30552616
Mol Biol Rep Β· 2019
0.80
5
A Significant Increasing Risk Association between Cigarette Smoking and
PMID: 37510255
Genes (Basel) Β· 2023
0.76